financetom
Business
financetom
/
Business
/
Etihad first-quarter profit jumps 30% on strong demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Etihad first-quarter profit jumps 30% on strong demand
May 26, 2025 11:23 AM

DUBAI (Reuters) - Etihad Airways' first-quarter profit after tax jumped 30% to 685 million dirhams ($186.52 million), it said on Wednesday, citing strong demand and improved operational efficiency.

Total revenue rose 15%, supported by growth in both passenger and cargo business.

Passenger revenue climbed 16% to 5.5 billion dirhams ($1.50 billion), bolstered by increased capacity, ongoing network expansion and more frequent flights.

"We are proud to deliver a record-breaking quarter - both in profitability and in guest satisfaction," said CEO Antonoaldo Neves.

($1 = 3.6726 UAE dirham)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
VCI Global Enters Alliance Led by Enlight, Super Micro Computer to Establish AI Computing Facilities
VCI Global Enters Alliance Led by Enlight, Super Micro Computer to Establish AI Computing Facilities
Jul 26, 2024
10:13 AM EDT, 07/26/2024 (MT Newswires) -- VCI Global ( VCIG ) said Friday it has entered into an artificial intelligence computing alliance led by Enlight and Super Micro Computer ( SMCI ) to set up AI computing facilities and accelerate the AI ecosystem. The first computing facility will be installed in Taiwan and will provide services to entities like...
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Jul 26, 2024
On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a negative opinion on the approval of Eisai Co., Ltd ( ESALF ) (OTC:ESALF) and Biogen Inc.’s lecanemab. The companies seek approval for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody as a treatment for early AD (mild cognitive impairment due to...
3M Raises Low End of 2024 Earnings Outlook as Second-Quarter Results Top Views
3M Raises Low End of 2024 Earnings Outlook as Second-Quarter Results Top Views
Jul 26, 2024
10:18 AM EDT, 07/26/2024 (MT Newswires) -- 3M ( MMM ) lifted the low end of its full-year earnings outlook on Friday after reporting second-quarter results above market estimates. The industrial conglomerate now expects adjusted earnings of $7 to $7.30 per share for 2024, compared with a $6.80 bottom end of its prior guidance range. The consensus among analysts on...
US charges Citron's Andrew Left over alleged multi-million fraud scheme
US charges Citron's Andrew Left over alleged multi-million fraud scheme
Jul 26, 2024
July 26 (Reuters) - U.S. authorities filed criminal and civil charges against prominent activist short seller Andrew Left for an alleged long-running market manipulation scheme involving bets on stocks including Nvidia ( NVDA ) and Tesla , they said on Friday. Left used his Citron Research website and social media platforms to recommend long or short positions in 23 companies,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved